Congenital myopathy Dilated cardiomyopathy Neuromuscular diseases Autoimmune diseases CMS Therapy Myogenesis Laminopathie Cancer Rare neuromuscular diseases Motoneuron Genotype phenotype correlation Heart Centronuclear myopathy Male Treatment Myotonic Dystrophy type 1 DMD Humans Thérapie génique Clinical trials Muscle Laminopathies Cardiomyopathy Lamin A/C Diagnosis Skeletal muscle OPMD Antisense oligonucleotides Myasthenia gravis Calcium Myositis Dystrophin Transgenic mouse model Rare diseases Myotonic Dystrophy Myoblasts Satellite cells Alternative splicing Heart failure Thymus PABPN1 Exercise Aged Autophagy Laminopathy Glutamate Myopathies Actin Inflammation Cytoskeleton Aging Cytokines Myasthenia Gravis MG AAV Regeneration Myopathy Mouse model FSHD Neuromuscular junction RNA interference Brain RNA biology LMNA gene Animals Nuclear envelope Gene therapy Duchenne muscular dystrophy Congenital muscular dystrophy Muscular dystrophy Muscle regeneration Becker muscular dystrophy ALS Biomarker Long read sequencing CTG repeat contractions Dermatomyositis Myotonic dystrophy type 1 Trinucleotide repeat expansion Cell therapy Fibrosis MBNL Errance diagnostique Dynamin 2 Autoimmunity Myotonic dystrophy Lamin A/C LMNA gene Amyotrophic lateral sclerosis Fabry disease Outcome measures Mechanotransduction CRISPRi Satellite cell LMNA Transcriptomics Astrocyte COVID-19 Biomarkers Neuromuscular disease Autoantibodies